Tubulin inhibitor 40
Tubulin inhibitor 40 (compound 45) is a tubulin inhibitor with IC50 of 1.2 μM. Tubulin inhibitor 40 shows selective cytotoxicity towards cancer cells. Tubulin inhibitor 40 processes antitumor activity .
For research use only. We do not sell to patients.
- CAS No.: 3026839-57-3
- Formula: C19H20N2O5
- Molecular Weight:356.37
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
0.005 μM (Tubulin, A549), 0.008 μM (Tubulin, VA13), 0.009 μM (Tubulin, MCF7’), 0.008 μM (Tubulin, HEK293T)[1]
In Vitro
Tubulin inhibitor 40 reveals cytotoxicity towards cell lines A549, VA13, MCF7’ and HEK293T, with IC50 values of 0.005 μM, 0.008 μM, 0.009 μM and 0.008 μM, respectively [1].
Tubulin inhibitor 40 inhibits tubulin polymerization with IC50 of 1.2 μM [1].
Tubulin inhibitor 40 (1-25 μM, 24 h) causes changes in cell morphology and tubulin assembly in A549[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:A549, VA13, MCF7’, HEK293T
-
Concentration:a range of concentrations from a few nM to 100 μM
-
Incubation Time:72 h
-
Result:Showed cytotoxicity towards cell lines A549, VA13, MCF7’ and HEK293T.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:antitumor efficacy in murine L1210 and P388 leukemia in BALB/c nude mice[1]
-
Dosage:20 mg/kg, i.v., 5 days
-
Administration:intravenous injection
-
Result:Showed T/C values of 233% and 324% for P388 and L1210 leukemia.
-
Animal Model:Antitumor Efficacy in Human Cancer Xenografts.SW620 in BALB/c nude mice[1]
-
Dosage:20 mg/kg, i.v., 5 days
-
Administration:i.v. .intravenous injection
-
Result:Reduced tumor growth by 74%.
Chemical Information
-
CAS No. 3026839-57-3
-
Molecular Weight 356.37
-
Formula C19H20N2O5
-
SMILES
COC1=C(C(OC)=CC(C2=CON=C2C3=CC=C(C(N)=C3)OC)=C1)OC
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Subcutaneous Cell-Line-Derived Xenograft
Subcutaneous cell-line-derived xenograft (CDX) models are established by implanting cultured human cancer cell lines into immunodeficient mice, where the injected cells form localized tumors that can be monitored in vivo as a measure of tumorigenic potential, growth kinetics, and treatment response. These models are widely used in oncology research because they allow reproducible tumor formation and enable comparative assessment of tumor growth between different cell lines or genetic manipulations in a controlled in vivo microenvironment. Subcutaneous implantation of cancer cells in immunodeficient mice is a standard approach for evaluating tumor growth behavior and therapeutic response across multiple cancer types, including prostate, esophageal, pancreatic, and colon cancer models.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)